Elizabeth S. Ahern

Fitzroy, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Salvage therapies for recurrent grade 4 IDH-wildtype glioma: a BRAIN Registry analysis of real-world treatment patterns.

Salvage therapies for recurrent grade 4 IDH-wildtype glioma: a BRAIN Registry analysis of real-world treatment patterns.

Journal: Journal of neuro-oncology

Published: December 23, 2025

Clinical Outcomes of the POPCORN Study: Pharmacodynamics of Pre-Operative PD1 CheckpOint Blockade and Receptor Activator of NF-κB Ligand (RANKL) Inhibition in Non-Small Cell Lung Cancer (NSCLC)-A Phase 1B/2 Trial.

Clinical Outcomes of the POPCORN Study: Pharmacodynamics of Pre-Operative PD1 CheckpOint Blockade and Receptor Activator of NF-κB Ligand (RANKL) Inhibition in Non-Small Cell Lung Cancer (NSCLC)-A Phase 1B/2 Trial.

Journal: Asia-Pacific journal of clinical oncology

Published: August 01, 2025

Factors that influence clinical trial participation for oncology patients in Australia: a scoping review.

Factors that influence clinical trial participation for oncology patients in Australia: a scoping review.

Journal: BMJ open

Published: June 12, 2025

Demonstration of a mobile optical clock ensemble at sea.

Demonstration of a mobile optical clock ensemble at sea.

Journal: Nature communications

Published: October 14, 2024

Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer.

Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer.

Journal: Vaccine

Published: September 07, 2024

Evolving Practice and Outcomes in Grade 2 Glioma: Real-World Data from a Multi-Institutional Registry.

Evolving Practice and Outcomes in Grade 2 Glioma: Real-World Data from a Multi-Institutional Registry.

Journal: Cancers

Published: September 04, 2024

Sacituzumab Govitecan in Patients with Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results from the Phase II TROPiCS-03 Basket Study.

Sacituzumab Govitecan in Patients with Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results from the Phase II TROPiCS-03 Basket Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 02, 2024

Improving Clinical Registry Data Quality via Linkage With Survival Data From State-Based Population Registries.

Improving Clinical Registry Data Quality via Linkage With Survival Data From State-Based Population Registries.

Journal: JCO clinical cancer informatics

Published: June 26, 2024

Corrigendum: Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.

Corrigendum: Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.

Journal: Frontiers in immunology

Published: June 01, 2024

Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).

Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).

Journal: Journal of neuro-oncology

Published: March 13, 2024

Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.

Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.

Journal: Journal of neuro-oncology

Published: January 30, 2024

Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.

Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.

Journal: Frontiers in immunology

Published: November 27, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026